# FDA WARNING_LETTER - N2G2, LLC d/b/a Lavoo Tobacco - May 14, 2019

Source: https://www.keypedia.com/records/warning_letter/n2g2-llc-dba-lavoo-tobacco/d3ee4513-49bd-4107-a49f-fc72d0b98926

> FDA WARNING_LETTER for N2G2, LLC d/b/a Lavoo Tobacco on May 14, 2019. Product: Tobacco. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: N2G2, LLC d/b/a Lavoo Tobacco
- Inspection Date: 2019-05-14
- Product Type: Tobacco
- Office Name: Center for Tobacco Products
- Summary: On April 26, 2019, the FDA issued a Warning Letter to Nader Marzok of Lavoo Tobacco, following a review of their website, lavootobacco.com. The FDA determined that Lavoo Tobacco's waterpipe tobacco products are subject to FDA jurisdiction.

The letter identifies two primary violations:
1.  **Sales to Minors:** Lavoo Tobacco sold Lavoo Tobacco Russian Tea waterpipe tobacco to a person younger than 18 years of age, violating 21 C.F.R. § 1140.14(b). This renders the product misbranded under section 903(a)(7)(B) of the FD&C Act.
2.  **Failure to Include Required Nicotine Warning Statement:** Several waterpipe tobacco products advertised and sold on the website, including Lavoo Tobacco Double Dark Mint, Southern Peach, and various Lavoo Heritage Reserve products, lacked the mandatory "WARNING: This product contains nicotine. Nicotine is an addictive chemical" statement. This violates 21 C.F.R. § 1143.3(a) and/or (b), causing these products to be misbranded under sections 903(a)(7)(B), 903(a)(1), and/or 903(a)(7)(A) of the FD&C Act.

The FDA requires immediate corrective

## Related Officers

- [Director](https://www.keypedia.com/people/ann-simoneau/155ef03c-6b60-4063-b35d-75522fa67d2b)

Company: https://www.keypedia.com/companies/n2g2-llc-dba-lavoo-tobacco/6f4ccead-af2d-4072-bd4b-6a507339c8cb

Office: https://www.keypedia.com/offices/center-for-tobacco-products/65f73cae-ef6f-4e9f-a311-a111daa67374